Form 10-Q

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of September 30, 2012, there were 575 and 7,734 of the Registrant’s Class A and Class B Redeemable Common Shares outstanding, respectively.

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE SHARES AND SHAREHOLDERS’ EQUITY

The condensed consolidated interim financial statements included in this report have been prepared by DCP Holding Company and subsidiaries (the “Company”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”). In the opinion of management, all adjustments (consisting of normal recurring accruals) necessary for a fair presentation are reflected in the interim financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the audited 2011 financial statements and notes thereto as included in the DCP Holding Company annual report on Form 10-K for the year ended December 31, 2011 filed with the Commission on March 19, 2012. These unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America for interim financial statements. Certain financial information that is required in the annual financial statements may not be required for interim financial reporting purposes and has been condensed or omitted. Operating results for the three and nine months ended September 30, 2012 are not necessarily indicative of the results that may be expected for the year ending December 31, 2012.

The Company changed its reportable segments in the first quarter of 2012 to reflect management’s revised view of the business and to align the external financial reporting with a new operating and internal reporting model. The Company has separated the fully-insured dental PPO product into its own segment as a result of recent revenue growth of the fully-insured dental PPO product and the unique sales and operations management considerations for this product in the Company’s expanding markets. All respective amounts related to the segment change have been retrospectively adjusted throughout the financial statements.

Adopted Accounting Standards—Effective January 1, 2012, the Financial Accounting Standards Board (“FASB”) amended the guidance for deferred acquisition costs and requires that only incremental direct costs of successful contract acquisition be capitalized. These incremental direct costs are those that are essential to the contract transaction and would not have been incurred had the contract transaction not occurred. On January 1, 2012, the impact of adoption on redeemable shares totaled approximately $125,000, net of tax. The Company has applied the retrospective method for financial statement presentation and note disclosures for the prior periods reported.

The following table illustrates the effect of the guidance change in the condensed consolidated balance sheets:

The following table illustrates the effect of the guidance change in the condensed consolidated statements of comprehensive income:

The interim condensed consolidated financial statements have been prepared in accordance with the accounting policies described in the notes to the Company’s consolidated financial statements for the year ended December 31, 2011. While management believes that the procedures followed in preparation of interim financial information are reasonable, the accompanying condensed consolidated financial statements include estimates for items such as changes in claims payable, deferred tax accounts, deferred acquisition costs, deferred share-based compensation and accrued expenses, among others. Any adjustments related to such estimates during the reporting period were of a normal recurring nature.

Use of Estimates—The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Fully-Insured—Membership contracts are written on an annual basis and are subject to cancellation by the employer group upon thirty days written notice. The Company’s unearned premium revenue was approximately $28,090,000 and $22,457,000 at September 30, 2012 and December 31, 2011, respectively, and primarily relates to the estimated premium revenue associated with the remaining contract periods. Related amounts recorded in unbilled accounts receivable were approximately $26,523,000 and $21,219,000 at September 30, 2012 and December 31, 2011, respectively. Premiums are due monthly in advance and are recognized evenly as revenue during the period in which the Company is obligated to provide services to members. Any amounts not received by the end of a reporting period are recorded as accounts receivable by the Company. Any premiums received prior to the beginning of a reporting period are recognized as premiums received in advance and are included in unearned premium revenue in the accompanying condensed consolidated balance sheets. Premiums received in advance were approximately $1,567,000 and $1,237,000 at September 30, 2012 and December 31, 2011, respectively. Management has determined that as of September 30, 2012 and December 31, 2011, respectively, no premium deficiency reserve is required. The Company’s premium deficiency reserve analysis includes an allocation of investment income.

Self-Insured—The Company provides administrative and claims processing services, benefit plan design, and access to its provider networks for an administrative fee to self-insured groups. The Company has no underwriting risk arising from the provision or cost of any services provided to the self-insured groups. The Company recognizes and records self-insured premiums on a gross basis because: (i) the Company is the primary obligor in its contractual relationships with self-insured employers and dental service providers, (ii) the Company establishes the pricing for the services provided, (iii) the Company controls the selection of and the relationships with the dental service providers, and (iv) the Company is involved in the determination of dental service specifications. Self-insured premium revenue is recognized upon the payment of claims for self-insured members in accordance with agreements with self-insured employers and is included in premium revenue in the accompanying condensed consolidated statements of comprehensive income.

Third-party administration fee revenue (“ASO fees”) is recognized monthly when earned and is normally based on annual contracts with the self-insured groups. ASO fees are charged to self-insured employer groups monthly on a per subscriber per month basis. ASO fees also include the administrative fees the Company earns relative to the dental PPO, dental indemnity and vision products that are underwritten by third-party insurance carriers.

Healthcare Services Expense— The Company compensates its providers based on contractual reimbursement for various services. With respect to the dental HMO product and, effective April 1, 2011, the in-network portion of the dental PPO product, the Company generally retains 10% of this reimbursement (including payments on self-insured claims) in accordance with the Company’s provider agreements. Healthcare services expense is recorded net of any amounts withheld in the accompanying condensed consolidated statements of comprehensive income. Under the terms of the Company’s provider agreements, the Company is not obligated to return to providers any amounts withheld. Withheld amounts are retained by the Company but not reserved or retained in a separate fund. Participating providers have no interest in the amounts withheld, unless the Company’s Board authorizes an amount to be paid to the providers.

Each year the Board evaluates the performance of the Company’s dental plans, capital and surplus requirements prescribed by the Ohio Department of Insurance, factors affecting the Company’s financial strength rating, funding needed to support strategic objectives for the coming years and any other factors deemed relevant by the Board and, based on that evaluation, determines whether or not to authorize the payment to the providers of any portion of the provider withhold. Once authorized by the Board, such amounts are recorded as additional healthcare services expense in the period authorized and shown as additional claims payable liability until paid.

The cost of fully-insured healthcare services to members is accrued in the period such services are provided based on the accumulation of estimates of claims reported prior to the end of a reporting period and of estimates of dental services incurred but not reported to the Company, net of the amounts withheld, in accordance with the provider agreements.

Management’s estimates of dental services provided are based on the Company’s historical experience and current trends, with assistance from the Company’s consulting actuary. Estimated dental claims payable are reviewed monthly by management and are adjusted based on current information, actual paid claims data, dental utilization statistics and other pertinent information. However, final claim payments may differ from the established reserves. Any resulting adjustments are reflected in current operations.

Investments—The Company invests in certificates of deposit, investment grade corporate bonds and money market funds. The Company classifies all investments as available-for-sale. The Company engages a fixed income portfolio manager to manage the Company’s investment grade corporate bonds, under the Company’s direction, in order to maximize investment returns. Such investments are recorded at fair value, with unrealized gains and losses recorded as a component of other comprehensive income. The Company recognizes gains and losses when these securities mature or are sold using the specific identification method.

Management follows a consistent and systematic process for recognizing impairments on securities that sustain other-than-temporary declines in value. The decision to record an other-than-temporary impairment for a security incorporates both quantitative criteria and qualitative information. The Company considers the severity of the loss on a security, duration of loss, duration of the investment, credit rating of the security, as well as payment performance and the Company’s intent or requirement to sell the investment before recovery when determining whether any impairment is other than temporary. The Company’s impairment policy for fixed-maturity securities states that other-than-temporary impairment is considered to have occurred if (1) the Company intends to sell the impaired fixed maturity security; (2) it is more likely than not that the Company will be required to sell the fixed maturity security before recovery of its amortized cost basis; or (3) the present value of the expected cash flows is not sufficient to recover the entire amortized cost basis.

State Guarantee Fund Deposits—The Company maintains funds on deposit with state insurance departments in those states where the Company is licensed to do business. These funds amounted to approximately $276,000 and $285,000 at September 30, 2012 and December 31, 2011, respectively. These funds are restricted and not available to the Company for normal operations and are included in other assets in the accompanying condensed consolidated balance sheets.

Deferred Acquisition Costs—Deferred acquisition costs are those incremental direct costs related to the successful acquisition of new and renewal business. These incremental direct costs are those that are essential to the contract transaction and would not have been incurred had the contract transaction not occurred. Such incremental direct costs include commissions, costs of contract issuance and underwriting, premium taxes and other costs the Company incurs to acquire successful new business or renew existing business. The Company defers policy acquisition costs and amortizes them over the estimated life of the contracts, which are short-duration in nature, in proportion to premiums earned. The Company capitalized deferred acquisition costs of approximately $853,000 and $848,000 and amortized approximately $883,000 and $986,000 of these capitalized costs for the three months ended September 30, 2012 and 2011, respectively. The Company capitalized deferred acquisition costs of approximately $2,977,000 and $3,012,000 and amortized approximately $2,691,000 and $2,929,000 of these capitalized costs for the nine months ended September 30, 2012 and 2011, respectively. The amortization of these costs are recorded in commission expense and other acquisition costs included in the condensed consolidated statements of comprehensive income.

Reinsurance—In the normal course of business, the Company assumes premium revenue and related healthcare services expense from a third party insurance provider. Dental insurance premium assumed was approximately $35,000 and $65,000 for the three months ended September 30, 2012 and 2011, respectively. Dental insurance premium assumed was approximately $162,000 and $194,000 for the nine months ended September 30, 2012 and 2011, respectively. The healthcare services expense assumed was approximately $41,000 and $59,000 for the three months ended September 30, 2012 and 2011, respectively. The healthcare services expense assumed was approximately $154,000 and $178,000 for the nine months ended September 30, 2012 and 2011, respectively. The Company had approximately $16,000 and $12,000 of reinsurance premium receivable and claims payable of approximately $13,000 and $20,000 at September 30, 2012 and December 31, 2011, respectively.

New Accounting Standards— In December 2011, the FASB issued updated guidance on the presentation of comprehensive income that was issued by the FASB in June 2011. The June 2011 guidance requires entities to present the total of comprehensive income, the components of net income and the components of other comprehensive income either in a single, continuous statement of comprehensive income or in two separate but consecutive statements. The updated December 2011 guidance defers these changes that relate to the presentation of adjustments between other comprehensive income and net income. The deferral of those changes allows the FASB time to further consider whether to require presentation on the face of the financial statements the effects of reclassifications out of accumulated other comprehensive income for all periods presented. The Company has adopted the new guidance and has elected to present one continuous condensed consolidated statement of comprehensive income. This did not have a material impact on the condensed consolidated financial statements.

In May 2011, the FASB issued guidance related to amendments to certain measurement principles and disclosures regarding fair value measurements. The amendments in this update improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with U.S. Generally Accepted Accounting Principles and International Financial Reporting Standards. This guidance is effective for fiscal years and interim periods beginning after December 15, 2011. The adoption of the guidance did not have a material impact on the condensed consolidated financial statements and related disclosures.

The Company owned certificates of deposit insured by the Federal Deposit Insurance Corporation (“FDIC”) with an amortized cost of $1,200,000 as of September 30, 2012 and December 31, 2011. The certificates of deposit included in short-term and fixed maturities investments are classified as available-for-sale and are carried at fair value. The Company also invests in money market funds included in short-term investments and are classified as available-for-sale, with a cost and fair value of approximately $87,000 and $108,000 as of September 30, 2012 and December 31, 2011, respectively. The Company invests in investment grade corporate bonds with an amortized cost of approximately $2,603,000 and $2,727,000 as of September 30, 2012 and December 31, 2011, respectively. The investment grade corporate bonds included in fixed maturities investments are classified as available-for-sale and are carried at fair value.

At September 30, 2012, the Company has thirty-three investment grade corporate bonds, which consist of twenty-five different securities each with a credit rating of A- or better and eight securities that had a credit rating of between BB+ and BBB+. The weighted average yield-to-book value of our investment grade corporate bonds was approximately 4.24% at September 30, 2012. The weighted average maturity of our investment grade corporate bonds was 8.19 years at September 30, 2012. The unrealized gains and losses on available-for-sale investment activity are due to a change in fair value for these investments caused primarily by changes in prevailing interest rates since they were purchased. There were approximately $40,000 and $15,000 of realized gains for the three and nine months ended September 30, 2012 and 2011, respectively.

At September 30, 2012 and December 31, 2011, maturity dates for fixed maturities and short-term investments (excluding the money market funds) were:

Investments classified at September 30, 2012 and December 31, 2011 as fixed maturities and short-term investments were as follows:

There were no gross unrealized losses at September 30, 2012. Unrealized losses at December 31, 2011 on investments were generally due to higher current market yields relative to the yields of the investments at their amortized cost. Unrealized losses due to credit risk associated with the underlying collateral of the investments, if any, are not material. All investments with unrealized losses are reviewed quarterly to determine if any impairment is other than temporary, requiring a charge to earnings. The Company considers the severity of the loss on a security, duration of loss, duration of the investment, credit rating of the security, as well as payment performance and the Company’s intent or requirement to sell the investment before recovery when determining whether any impairment is other than temporary. The Company had no other than temporary impairment charges for the three and nine months ended September 30, 2012 and 2011. The Company had no investments in a continuous unrealized loss position for greater than one year as of September 30, 2012 and December 31, 2011.

Share-based compensation cost is measured at the grant date based on the fair value of the liability awards and is recognized as expense ratably over the vesting periods and is included in other insurance expense in the condensed consolidated statements of comprehensive income. The fair value of the liability awards is remeasured at the end of each reporting period through the remaining vesting period with the change in fair value recognized in earnings currently.

In accordance with the 2006 Dental Care Plus Management Equity Incentive Plan and the Dental Care Plus, Inc. and DCP Holding Company Deferred Compensation Plan (the “Plans”), Company directors and certain key employees elected to defer portions of their director fees and employee compensation, as applicable. The Company recorded expense of approximately $20,000 and $15,000 related to deferred director fees and deferred employee compensation for the three months ended September 30, 2012 and 2011, respectively. The Company recorded expense of approximately $67,000 and $45,000 related to deferred director fees and deferred employee compensation for the nine months ended September 30, 2012 and 2011, respectively. Directors and key employees who elect to defer cash compensation may request that the Company invest this compensation in a mutual fund investment or phantom shares of the Company.

The Plans also provide for the directors and key employees to receive share awards based on the book value of the Redeemable Common Shares and to elect to defer receiving such amounts until termination of board membership or employment and vesting requirements are met. If a director or key employee does not elect to defer receiving his or her share awards, the individual will receive Class B Redeemable Common Shares upon vesting. If the share awards are deferred, these deferred amounts will be paid in cash at redemption. An individual director’s award vests 100% at the end of each year if the director meets certain attendance requirements. The key employee awards vest 10%, 20%, 30% and 40% at the end of each respective year in a four-year period following the grant date. There are no performance criteria associated with the vesting of the awards for key employees and the only requirement for vesting is that the individual is an employee of the Company at the end of the vesting year in question. In 2012, the Company established a long-term incentive compensation program for named executive officers pursuant to which an officer may receive an award of up to 45% of such officer’s base salary in the form of share awards which will vest if established Company performance criteria are achieved over a three year period.

The deferred compensation expense related to these awards is recorded ratably during the applicable vesting period. The Company recorded deferred compensation expense of approximately $50,000 and $48,000 related to deferred share awards and the change in the value of phantom shares for the three months ended September 30, 2012 and 2011, respectively. The Company recorded deferred compensation expense of approximately $152,000 and $113,000 related to deferred share awards and the change in the value of phantom shares for the nine months ended September 30, 2012 and 2011, respectively. As of September 30, 2012, there is approximately $239,000 of total unrecognized compensation cost related to non-vested award compensation under the Plans. That cost is expected to be recognized over a weighted average period of 1.80 years.

In March 2012, the Board declared a $21.00 per share dividend for all Class A and Class B redeemable common shares. With the dividend, the holders of restricted share units and phantom shares received an equivalent share based dividend that resulted in an increase in the deferred compensation liability of approximately $28,000.

The expected fair value of the awards is calculated by applying the three year historical average trend rate of the book value per redeemable common share over the respective vesting period. The weighted average grant date fair value of the awards granted in the nine months ended September 30, 2012 and 2011 were $741 and $639, respectively. At September 30, 2012 and December 31, 2011, the deferred compensation liability was approximately $1,411,000 and $1,196,000, respectively.

The following is a summary of activity of non-vested awards for the nine months ended September 30, 2012:

There were no share awards that vested during the three and nine months ended September 30, 2012.

The Company manages its business with four segments: fully-insured dental HMO and indemnity, fully-insured dental PPO, self-insured dental and corporate, all other. Self-insured dental consists of the self-insured dental HMO, self-insured dental PPO and self-insured dental indemnity products. Corporate, all other consists of revenue associated with the Company’s dental indemnity, dental PPO, and vision products underwritten by third-party insurance carriers and certain other corporate activities. These segments are consistent with information used by the Chief Executive Officer (the chief operating decision maker) in managing the business. The segment information aggregates products with similar economic characteristics. These characteristics include the nature of employer groups, pricing, benefits and underwriting requirements. The Company changed the composition of its reportable segments in the first quarter of 2012, and the amounts in the prior period financial statements relating to reportable segments have been modified to conform to the current composition of reportable segments. The Company changed the reportable segments to reflect managements’ view of the dental PPO products in the Company’s expanding markets. Prior to 2012, the Company managed its business with three segments: dental fully-insured, dental self-insured and corporate, all other.

The results of the fully-insured dental HMO and indemnity, fully-insured dental PPO and self-insured dental segments are measured by gross profit. The Company does not allocate insurance expense, investment and other income, assets or liabilities to these segments because the Company does not use these measures to analyze the segments. These items are assigned to the remainder of the Company’s business, which it identifies as corporate, all other. The Company’s gross profit, which is defined as premium revenue less healthcare services expense, was approximately $4,265,000 and $3,649,000 for the three months ended September 30, 2012 and 2011, respectively. The Company’s gross profit was approximately $11,525,000 and $9,899,000 for the nine months ended September 30, 2012 and 2011, respectively.

Listed below is financial information required for each reportable segment for the three and nine months ended September 30, 2012 and 2011 (amounts in thousands):

Inter-segment revenues were not significant for the three and nine months ended September 30, 2012 and 2011.

The Company calculates its year to date income tax provision by applying the estimated annual effective tax rate for the year to pretax income. The income tax expense for the three months ended September 30, 2012 was approximately $367,000 with an effective tax rate of 37.1%. The income tax expense for the three months ended September 30, 2011 was approximately $163,000 with an effective tax rate of 36.4%. The income tax expense for the nine months ended September 30, 2012 was approximately $468,000 with an effective tax rate of 36.6%. The income tax expense for the nine months ended September 30, 2011 was approximately $96,000 with an effective tax rate of 36.6%. Tax years subsequent to 2008 remain open to examination by the Internal Revenue Service (“IRS”), and 2007 remains open to state and local tax authorities. The Company has recorded no uncertain tax positions in the tax years that are subject to examination.

In 2003, the Company purchased land and an office building and in connection therewith, the Company executed a mortgage note with a bank, secured by the land and the office building, in the amount of $1,800,000. Interest is payable based on the 30-day LIBOR rate plus 1.75% and was 1.98% and 2.03% at September 30, 2012 and December 31, 2011, respectively. At September 30, 2012, the carrying value of the mortgage note of $690,000 approximates fair value. The Company validates the fair value of the mortgage note by using a discounted cash flow model and consideration of market interest rates for similar debt instruments. The mortgage note fair value disclosure is classified as Level 2 in the fair-value hierarchy. The Company also entered into an interest rate swap agreement that effectively changed the interest rate related to $1,500,000 of the Company’s $1,800,000 mortgage note with a commercial bank from a variable rate based on the 30-day LIBOR rate plus 1.75% to a fixed rate of approximately 4.95% for the 10-year period through June 12, 2013 (see Note 8).

The Company has a revolving note with a commercial bank in the amount of $750,000 collateralized by a second mortgage on the office building that matures in December 2012. There was a principal balance outstanding of $650,000 at September 30, 2012 and December 31, 2011. Interest is payable based on the 30-day LIBOR rate plus 1.75% and was 1.98% and 2.03% at September 30, 2012 and December 31, 2011, respectively. At September 30, 2012, the carrying value of the revolving note approximates fair value. The Company validates the fair value of the revolving note by using a discounted cash flow model and consideration of market interest rates for similar debt instruments. The revolving note fair value disclosure is classified as Level 2 in the fair-value hierarchy.

The Company has an annually renewable agreement with a commercial bank for a $500,000 working capital line of credit. Interest is payable at a variable rate of LIBOR plus 2.50% and was 2.74% and 2.88% at September 30, 2012 and December 31, 2011, respectively. The Company did not have any interest expense or significant fees for the line of credit for the nine months ended September 30, 2012 and 2011. As of September 30, 2012 and December 31, 2011, there was no amount outstanding on this line of credit. The $500,000 working capital line of credit expires in July 2013.

The Company has an additional annually renewable working capital line of credit for $960,000. Interest is payable at a variable rate of LIBOR plus 2.50% and was 2.74% and 2.88% at September 30, 2012 and December 31, 2011, respectively. The Company did not have any interest expense for the line of credit in the nine months ended September 30, 2012 and 2011. At September 30, 2012 and December 31, 2011, there was no amount outstanding on this line of credit. The $960,000 working capital line of credit expires in August 2013. In addition, the Company obtained an irrevocable letter of credit for $40,000, with interest payable on all outstanding amounts at a variable rate of the prime rate of borrowing plus 6.00%. The letter of credit also has an annual fixed rate of 2.10% for access to the letter of credit obligation. The letter of credit expires in December 2012. At September 30, 2012 and December 31, 2011, there was no amount outstanding on the irrevocable letter of credit obligation.

The Company classifies the assets and liabilities that require measurement of fair value on a recurring basis based on the priority of the observable and market-based sources of data into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are as follows:

The following table presents for each of the fair value levels, the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2012 and December 31, 2011 (amounts in thousands):

The Company measures fair value using the following valuation methodologies. The Company uses quoted market prices to determine the fair value of the deferred compensation investments and certain state fund guarantee deposits; such items are classified as Level 1 of the fair-value hierarchy. Examples include government securities and exchange-traded equity securities. The Company primarily bases fair value for investments in fixed-maturity securities (including federally-insured certificates of deposits and investment grade corporate bonds) on quoted market prices or on prices from a pricing vendor, an outside resource that supplies independent securities pricing, dividend, corporate action and descriptive information to support fund pricing, securities operations, research and portfolio management. The Company obtains and reviews the pricing service’s valuation methodologies and validates these prices using various inputs including quotes from other independent regulatory sources. When deemed necessary, the Company validates prices by replicating a sample using a discounted cash flow model. Such items are classified as Level 2 of the fair-value hierarchy. The Company obtains a price from an independent vendor to determine the fair value of the interest rate swap. The independent vendor uses a discounted cash flow method whereby the significant observable inputs include the replacement interest rates of similar swap instruments in the market and swap curves; such items are classified as Level 2 of the fair value hierarchy.

As of September 30, 2012 and December 31, 2011, there were no assets or liabilities that were required to be measured at fair value on a non-recurring basis.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Portions of this report, including this discussion and the information contained in the notes to the condensed consolidated financial statements, contain forward-looking statements under the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by words such as “may,” “might,” “will,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “predict,” “intend,” “potential,” “likely will result,” or the negative of such terms or similar expressions. These forward-looking statements reflect our current expectations and views about future events and speak only as of the date of this report. The forward-looking statements are subject to risks, uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements, include, among others: claims costs exceeding our estimates, a downgrade in our financial strength rating, competitive pressures, changes in demand for dental benefits and other economic conditions, the loss of a significant customer or broker, the occurrence or non-occurrence of circumstances beyond our control and those items described in Item 1A – Risk Factors of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011. We do not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date this report is filed.

Headquartered in Cincinnati, Ohio, we offer dental HMO, dental indemnity, dental PPO and vision PPO benefit plans and related services, primarily to employer groups of two or more employees. As of September 30, 2012, we had approximately 296,500 members in our dental and vision benefit programs with approximately 2,700 dentists participating in our dental HMO network and approximately 2,900 dentists participating in our dental PPO network. Effective June 1, 2011, the Company entered into a network leasing agreement with a national dental network management company that has one of the largest PPO networks of dentists under contract in the United States. With this network leasing agreement, Dental Care Plus dental PPO members now have access to approximately 2,200 additional dentists in Ohio, Kentucky and Indiana and approximately 38,500 additional dentists throughout the United States.

We changed our reportable segments in the first quarter of 2012 to reflect management’s recent view of the business and to align our external financial reporting with our new operating and internal reporting model. We have separated the fully-insured dental PPO product into its own segment as a result of recent revenue growth of the fully-insured dental PPO and the unique sales and operations management considerations for this product in the Company’s expanding markets. All respective amounts related to the segment change have been retrospectively adjusted throughout the financial statements.

We manage our business with four reportable segments: fully-insured dental HMO and indemnity (“dental HMO/IND”), fully-insured dental PPO, self-insured dental, and corporate, all other. Self-insured dental consists of the self-insured dental HMO, self-insured dental PPO and self-insured dental indemnity products. Corporate, all other primarily consists of revenue associated with our dental and vision products underwritten by third-party insurance carriers and certain other corporate activities. Our dental HMO/IND and PPO products and our vision product line are primarily marketed to employer groups. The results of our fully-insured dental HMO/IND, fully-insured dental PPO and self-insured dental segments are measured by gross profit. We do not measure the gross profit of our corporate, all other segment. We do not allocate investment and other income, insurance expenses, assets or liabilities to our segments because these measures are not used to analyze the segments. Our segments do not share overhead costs or assets. We do, however, measure the contributions of each of our fully-insured and self-insured segments to costs retained in our corporate, all other segment.

Many factors have an effect on our results, but most notably our results are influenced by our ability to establish and maintain a competitive and efficient cost structure and to accurately and consistently establish competitive premiums, ASO fees, and plan benefit levels that are commensurate with our dental and administrative costs. Dental costs are subject to a high rate of inflation due to many factors, including new higher priced technologies and dental procedures, new dental service techniques and therapies, an aging population, lifestyle choices, the tort system and government regulations.

Our strategy focuses on providing solutions to employers to the rising cost of dental care by leveraging our growing networks of participating dentists and deploying a variety of products that give employer groups and members more choices. We strive to provide excellent customer service to our employers, members and participating dentists. Additionally, we have increased the diversification of our membership base, not only through our newer products, but also by entering new geographic territories. We expect our dental PPO products to be important components of growth in the years ahead.

In our original eight county service area, our non-exclusive dental HMO provider network includes over 95% of the dental providers in the market. In that market, our dental HMO provides the broad provider access of a dental PPO along with effective utilization and cost control features.

The following is a discussion of our results of operations for the three months ended September 30, 2012, (the “2012 quarter”), the three months ended September 30, 2011, (the “2011 quarter”), the nine months ended September 30, 2012, (the “2012 period”) and the nine months ended September 30, 2011, (the “2011 period”).

The following table presents membership and financial data for our four reportable segments (dollar amounts in thousands):

Fully-insured dental HMO/IND premium revenue increased by $1,028,000 in the 2012 period from the 2011 period, and fully-insured dental HMO/IND premium on a per member per month (“PMPM”) basis increased by 2.0%, from $24.16 PMPM in the 2011 period to $24.64 PMPM in the 2012 period due to rate increases obtained on renewal business. Fully-insured dental PPO premium revenue increased by $1,293,000 in the 2012 period from the 2011 period, and fully-insured dental PPO premium on a PMPM basis increased by 7.9%, from $21.08 PMPM in the 2011 period to $22.75 PMPM in the 2012 period due to rate increases obtained on renewal business.

Fully-insured dental HMO/IND healthcare services expense increased by $128,000 in the 2012 period from the 2011 period, and fully-insured dental HMO/IND healthcare services expense on a PMPM basis decreased by 0.7%, from $19.29 PMPM in the 2011 period to $19.15 PMPM in the 2012 period. The lower level of dental HMO/IND healthcare services expense on a PMPM basis resulted in a decrease in healthcare services expense of $189,000. In addition, an increase in dental HMO/IND healthcare services expense of $317,000 was the result of an increase in membership volume in the 2012 period compared to the 2011 period.

Fully-insured dental PPO healthcare services expense increased by $610,000 in the 2012 period from the 2011 period, and fully-insured dental PPO healthcare services expense on a PMPM basis decreased by 0.1%, from $19.23 PMPM in the 2011 period to $19.22 PMPM in the 2012 period. This decrease is primarily the result of the 10% withhold on in-network claims that was not implemented for the in-network dental PPO product until April 1, 2011. The lower level of dental PPO healthcare services expense on a PMPM basis resulted in a decrease in healthcare services expense of $6,000 that was offset by an increase in dental PPO healthcare services expense of $616,000 due to an increase in membership volume in the 2012 period compared to the 2011 period.

Self-insured healthcare services expense increased by $141,000 in the 2012 period from the 2011 period. An increase in self-insured membership volume resulted in an increase of $382,000 in the 2012 period that was offset by a decrease in self-insured healthcare services expense of approximately $241,000 due to a 1.5% decrease in self-insured claims on a PMPM basis.

Insurance expense increased by $660,000 in the 2012 period compared to the 2011 period. This insurance expense increase is primarily attributable to higher broker commission expense, salaries and wages, advertising expense, accounting and audit related expenses and professional consulting expenses in the 2012 period compared to the 2011 period. Insurance expense as a percentage of total revenue, or the insurance expense ratio, was 17.4% for the 2012 period compared to 17.0% for the 2011 period.

Our fully-insured dental HMO/IND membership increased by approximately 1,500 members as of September 30, 2012 from September 30, 2011. This membership increase is primarily attributable to an increase of approximately 2,100 fully-insured dental HMO members offset by a decrease of approximately 600 fully-insured dental indemnity members. The increase in fully-insured dental HMO membership is the result of new sales of approximately 12,100 members, offset by the loss of approximately 10,000 members due to employer groups that did not renew with the Company or reduced employee counts of retained employer groups. A portion of the fully-insured dental HMO membership losses were the result of corporate acquisitions where our employer group customers moved to the new parent company benefit plans and some of our membership losses were the result of employer groups moving to medical carriers to take advantage of medical/dental package savings. The decrease in fully-insured dental indemnity membership is primarily the result of the shift of these members to our fully-insured dental PPO after the introduction of the national PPO network in June 2011.

Our fully insured dental PPO membership increased by approximately 3,100 members as of September 30, 2012 from September 30, 2011. The increase in fully-insured dental PPO membership is the result of new sales in Ohio and Kentucky of approximately 7,900 members, offset by the loss of approximately 4,700 members due to employer groups that did not renew with the Company or reduced employee counts of retained employer groups.

Our self-insured dental membership increased by approximately 1,600 members as of September 30, 2012 from September 30, 2011. This increase is primarily due to the addition of new self-insured dental HMO and dental PPO employer groups in the last twelve months and growth within existing employer groups.

Our corporate, all other membership decreased by approximately 300 members as of September 30, 2012 from September 30, 2011. Our vision plan membership decreased by approximately 200 members. Also there was a decrease of approximately 100 dental indemnity members underwritten by a third party insurance carrier that shifted into the fully-insured HMO/IND segment at renewal.

Fully-insured dental HMO/IND premium revenue for the 2012 quarter increased by approximately $233,000 compared to the 2011 quarter. Fully-insured dental HMO/IND premium rate increases negotiated with employer groups at their renewals resulted in an increase of approximately $108,000 in fully-insured dental HMO/IND premium revenue. An increase in fully-insured HMO/IND membership in the 2012 quarter resulted in an increase in fully-insured dental HMO/IND premiums of approximately $125,000.

Fully-insured dental HMO/IND premium revenue for the 2012 period increased by approximately $1,028,000 compared to the 2011 period. Fully-insured dental HMO/IND premium rate increases negotiated with employer groups at their renewals resulted in an increase of approximately $631,000 in fully-insured dental HMO/IND premium revenue. An increase in fully-insured HMO/IND membership in the 2012 period resulted in an increase in fully-insured dental HMO/IND premiums of approximately $397,000. The fully-insured dental HMO/IND segment represents approximately 54.8% of our total dental business.

Fully-insured dental PPO premium revenue for the 2012 quarter increased by approximately $492,000 compared to the 2011 quarter. Fully-insured dental PPO premium rate increases negotiated with employer groups at their renewals resulted in an increase of approximately $267,000 in fully-insured dental PPO premium revenue. An increase in fully-insured PPO membership in the 2012 quarter resulted in an increase in fully-insured dental PPO premiums of approximately $225,000.

Fully-insured dental PPO premium revenue for the 2012 period increased by approximately $1,293,000 compared to the 2011 period. Fully-insured dental PPO premium rate increases negotiated with employer groups at their renewals resulted in an increase of approximately $619,000 in fully-insured dental PPO premium revenue. An increase in fully-insured PPO membership in the 2012 period resulted in an increase in fully-insured dental PPO premiums of approximately $675,000. The fully-insured dental PPO segment represents approximately 14.1% of our total dental business.

Total self-insured dental revenue for the 2012 quarter increased approximately $12,000 compared to the 2011 quarter. Self-insured dental revenue increased by $104,000 due to new self-insured sales. This self-insured revenue increase was offset by a decrease of approximately $117,000 due to a decrease in the self-insured claims revenue on a PMPM basis as a result of lower dental service utilization.

Total self-insured dental revenue for the 2012 period increased approximately $182,000 compared to the 2011 period. Self-insured dental revenue increased by $444,000 due to new self-insured sales. This self-insured revenue increase was offset by a decrease of approximately $262,000 due to a decrease in the self-insured claims revenue on a PMPM basis as a result of lower dental service utilization. The self-insured dental segment represents approximately 30.4% of our total dental business.

Self-Insured Claim Revenue - Self-insured claim revenue for the 2012 quarter decreased approximately $28,000, or 0.5%, to approximately $6,116,000 in the 2012 quarter from approximately $6,144,000 in the 2011 quarter. Self-insured claim revenue increased by approximately $99,000 due to new self-insured sales. This self-insured claims revenue increase was offset by a decrease of approximately $128,000 primarily due to a decrease in the self-insured claims revenue on a PMPM basis as a result of lower dental service utilization.

Self-insured claim revenue for the 2012 period increased approximately $150,000, or 0.9%, to approximately $17,263,000 in the 2012 period from approximately $17,113,000 in the 2011 period. Self-insured claim revenue increased by approximately $422,000 due to new self-insured sales. This self-insured claims revenue increase was offset by a decrease of approximately $273,000 primarily due to a decrease in the self-insured claims revenue on a PMPM basis as a result of lower dental service utilization.

Self-Insured ASO Fees - Self-insured ASO fees for the 2012 quarter increased approximately $16,000, or 5.4%, to approximately $310,000 in the 2012 quarter from approximately $294,000 in the 2011 quarter. Self-insured ASO fees increased by approximately $5,000 due to the new self-insured product sales and by approximately $11,000 due to an increase in average self-insured ASO fee rates for the 2012 quarter compared to the 2011 quarter.

Self-insured ASO fees for the 2012 period increased approximately $32,000, or 3.6%, to approximately $934,000 in the 2012 period from approximately $902,000 in the 2011 period. Self-insured ASO fees increased by approximately $22,000 due to the new self-insured product sales and by approximately $10,000 due to an increase in average self-insured ASO fee rates for the 2012 period compared to the 2011 period.

Corporate, all other premium revenue is primarily derived from the dental indemnity product and the vision product that are underwritten by third-party insurance carriers. In aggregate, corporate, all other premium revenue decreased by approximately $5,000 in the 2012 quarter compared to the 2011 quarter. In aggregate, corporate, all other premium revenue increased by approximately $2,000 in the 2012 period compared to the 2011 period. The corporate, all other segment represents approximately 0.6% of our total dental business.

Investment income for the 2012 quarter increased approximately $12,000 compared to the 2011 quarter. Investment income for the 2012 period increased approximately $22,000 compared to the 2011 period. These increases are primarily attributable to an increase in the yield to maturity related to the current investment grade corporate bond portfolio with a longer average duration than the corporate bonds in place during the 2011 period and the 2012 period.

Fully-insured dental HMO/IND healthcare services expense for the 2012 quarter decreased approximately $102,000 compared to the 2011 quarter. An increase in fully-insured dental HMO/IND membership resulted in an increase in fully-insured dental HMO/IND healthcare services expense of $97,000. A decrease in fully-insured dental HMO/IND healthcare services expense on a PMPM basis resulted in a decrease in fully-insured dental HMO/IND healthcare services expense of approximately $199,000. The decrease is primarily the result of lower healthcare services utilization in the 2012 quarter compared to the 2011 quarter.

Fully-insured dental HMO/IND healthcare services expense for the 2012 period increased approximately $128,000 compared to the 2011 period. An increase in fully-insured dental HMO/IND membership resulted in an increase in fully-insured dental HMO/IND healthcare services expense of $317,000. A decrease in fully-insured dental HMO/IND healthcare services expense on a PMPM basis resulted in an decrease in fully-insured dental HMO/IND healthcare services expense of approximately $189,000. The decrease is primarily the result of lower healthcare services utilization in the 2012 period compared to the 2011 period.

Fully-insured dental PPO healthcare services expense for the 2012 quarter increased approximately $223,000 compared to the 2011 quarter. This increase was primarily the result of an increase in fully-insured dental PPO healthcare services expense of approximately $201,000 related to the increase in fully-insured dental PPO membership discussed above. This increase was also the result of an increase in fully-insured dental PPO healthcare services expense of approximately $22,000 related to an increase in fully-insured dental PPO healthcare services expense on a PMPM basis from $18.82 in the 2011 quarter to $19.00 in the 2012 quarter, due to higher healthcare services utilization in the 2012 quarter compared to the 2011 quarter.

Fully-insured dental PPO healthcare services expense for the 2012 period increased approximately $610,000 compared to the 2011 period. This increase was primarily the result of an increase in fully-insured dental PPO healthcare services expense of approximately $616,000 that was the result of the increase in fully-insured dental PPO membership discussed above. This increase was offset by a decrease in fully-insured dental PPO healthcare services expense of approximately $6,000 that was the result of a decrease in fully-insured dental PPO healthcare services expense on a PMPM basis. This decrease is primarily attributable to the introduction of a 10% provider withhold on the in-network portion of the dental PPO product on April 1, 2011. This 10% provider withhold was in effect for all nine months of the 2012 period but only for six months of the 2011 period. The decrease in fully-insured dental PPO healthcare services expense on a PMPM basis attributable to the 10% provider withhold for all nine months of 2012 was offset by an increase due to higher healthcare services utilization in the 2012 period compared to the 2011 period.

Self-insured dental healthcare services expense for the 2012 quarter decreased approximately $29,000 compared to the 2011 quarter. The self-insured new sales resulted in an increase in self-insured dental healthcare services expense of approximately $90,000. Offsetting this increase was a decrease of approximately $119,000 primarily due to a decrease in the self-insured healthcare services expense on a PMPM basis as a result of lower dental service utilization.

Self-insured dental healthcare services expense for the 2012 period increased approximately $141,000 compared to the 2011 period. The self-insured new sales resulted in an increase in self-insured dental healthcare services expense of approximately $382,000. Offsetting this increase was a decrease of approximately $241,000 primarily due to a decrease in the self-insured healthcare services expense on a PMPM basis as a result of lower dental service utilization.

Corporate, all other healthcare services expense is not recognized by the Company due to the fact that our other dental indemnity, dental PPO and vision PPO products are underwritten by third-party insurance carriers.

Consolidated insurance expense for the 2012 quarter increased approximately $116,000 compared to the 2011 quarter. Consolidated insurance expense for the 2012 period increased approximately $661,000 compared to the 2011 period. The higher consolidated insurance expense for both the 2012 quarter and the 2012 period was primarily due to higher broker commission expense on increased premium revenues, salaries and wages, advertising expense, accounting and audit related fees and professional consulting expenses. Insurance expense as a percentage of total revenue, or the insurance expense ratio, was 16.5% for the 2012 quarter compared to 16.5% for the 2011 quarter and 17.4% for the 2012 period compared to 17.0% for the 2011 period.

The Company calculates its year to date income tax provision by applying the estimated annual effective tax rate for the year to pretax income. Our income tax expense for the three months ended September 30, 2012 was approximately $367,000 with an effective tax rate of 37.1%. Our income tax expense for the three months ended September 30, 2011 was approximately $163,000 with an effective tax rate of 36.4%. Our income tax expense for the nine months ended September 30, 2012 was approximately $468,000 with an effective tax rate of 36.6%. Our income tax expense for the nine months ended September 30, 2011 was approximately $96,000 with an effective tax rate of 36.6%.

Our primary sources of cash include receipts of premiums, ASO fees, investment and other income proceeds from the sale or maturity of our investment securities, as well as from the sale of redeemable common and preferred shares and from borrowings. Our primary uses of cash include disbursements for claims payments, insurance expense, interest expense, taxes, purchases of investment securities, capital expenditures, redeemable common share redemptions and payments on borrowings. Cash increased approximately $1,683,000, or 24.1%, during the 2012 period to approximately $8,659,000 as of September 30, 2012 from approximately $6,976,000 as of December 31, 2011. The change in cash for the 2012 and 2011 periods is summarized as follows (in thousands):

In the 2012 period, approximately $1,094,000 was provided by operating activities. We had net income of approximately $811,000. This income is primarily attributable to an increase in our fully-insured dental HMO/IND and fully-insured dental PPO premium revenue on a PMPM basis and lower healthcare services expense utilization. In addition, in the 2012 period, our claims payable liability increased by approximately $41,000 resulting in a cash balance increase. Other payables and accrued expenses decreased by approximately $105,000, primarily due to a decrease in accounts payable of approximately $147,000, a decrease in our premium tax liability of approximately $83,000, and a decrease in our federal income tax payable of approximately $167,000, offset by an increase in accrued payroll, bonus and PTO of approximately $111,000, an increase in accrued broker commissions of approximately $127,000 and an increase in other accrued expenses of approximately $35,000. As disclosed in the condensed consolidated statements of cash flows, we paid $635,000 of federal income taxes in the 2012 period that related to our 2011 extension payment and 2012 estimated tax payments that was necessary because of our return to profitability in 2011 and 2012. The remaining effects of changes in operating assets and liabilities that represent fluctuations are not significant and are consistent with the 2011 period.

In the 2012 period, we invested approximately $61,000 in building improvements, furniture and fixtures and computer equipment. During the 2012 period, we made purchases totaling approximately $884,000 of investment grade corporate bonds, certificates of deposit and institutional money market funds in order to improve investment income. In the 2012 period, we invested $40,000 in a joint venture. Also during the 2012 period, we had certificate of deposit maturities and institutional money market sales that together totaled approximately $1,067,000.

In the 2012 period, we made the scheduled principal payments of approximately $90,000 related to our office building mortgage and scheduled payments of approximately $80,000 related to our capital lease. During the 2012 period, we repurchased previously redeemed Common Shares with a value of approximately $101,000 and issued Redeemable Common Shares with a value of approximately $23,000 to two members of the Board of Directors. In January 2012, we sold 1,000 Redeemable Institutional Preferred Shares at a purchase price of $1,000 per share, for an aggregate purchase price of $1,000,000, to a large Ohio based insurance company. We also paid dividends of approximately $177,000 to holders of our Redeemable Common Shares and approximately $67,000 to holders of our Redeemable Institutional Preferred Shares in the 2012 period.

In most cases, our reimbursement to our participating providers for covered dental services under the dental HMO and the dental PPO are generally subject to a 10% withhold by us. The 10% withhold related to the dental PPO product was effective April 1, 2011. The amounts withheld are not retained in a separate fund and we have no obligation to pay any portion of the amounts withheld to the providers. The dental providers have no vested rights in the amounts withheld unless our Board of Directors authorizes that any amounts withheld shall be paid to the providers, and then vesting is only to the extent of such amounts authorized to be paid by the Board. Once authorized for payment by the Board, such amounts are recorded as claims payable liabilities until paid.

In the 2012 and 2011 periods, we paid no withhold return to participating providers because a withhold return was not authorized by the Board of Directors.

Contractual Obligations, other Commitments and Off-balance Sheet Arrangements

Refer to the Company’s 2011 Annual Report on Form 10-K filed with the SEC for a description of contractual obligations, other commitments and off-balance sheet arrangements. We have had no significant changes in these items in 2012.

Our consolidated cash and short-term investments were approximately $9.0 million as of September 30, 2012 and approximately $7.3 million as of December 31, 2011. This increase is due to the increase in cash of approximately

$1,683,000 during the 2012 period and the increase in short-term investments of approximately $81,000 during the 2012 period. The increase in cash was primarily due to the cash provided by operating activities of approximately $1,094,000, cash provided financing activities of $507,000, and cash provided by investing activities of approximately $82,000. We expect to generate positive cash flow from operations during the balance of 2012. Based on total expenses for the nine months ended September 30, 2012, we estimate that we had approximately 41 days of cash and short-term investments on hand at September 30, 2012. In addition, the Company has access to approximately $3.7 million of fixed maturity investments that are classified as available-for-sale and two working capital lines of credit discussed below.

We have an annually renewable agreement with a commercial bank for a $500,000 working capital line of credit. Interest is payable at a variable rate of LIBOR plus 2.50% and was 2.74% and 2.88% at September 30, 2012 and December 31, 2011, respectively. We did not have any interest expense or significant fees for the line of credit in the 2012 period or the 2011 period. As of September 30, 2012 and December 31, 2011, there was no amount outstanding on this line of credit. The $500,000 working capital line of credit expires in July 2013. We expect to renew the working capital line of credit in July 2013.

We have an annually renewable second working capital line of credit for $960,000. Interest is payable at a variable rate of LIBOR plus 2.50% and was 2.74% and 2.88% at September 30, 2012 and December 31, 2011, respectively. The Company did not have any interest expense for the line of credit in the 2012 period or the 2011 period. At September 30, 2012 and December 31, 2011, there was no amount outstanding on this line of credit. The $960,000 working capital line of credit in August 2013. In addition, the Company obtained an irrevocable letter of credit for $40,000, with interest payable on all outstanding amounts at a variable rate of the prime rate of borrowing plus 6.00%. We expect to renew the working capital line of credit and the irrevocable letter of credit in August 2013.

On December 16, 2011, we renewed our revolving note with a commercial bank in the amount of $750,000 collateralized by a second mortgage on our office building. As of September 30, 2012, there was a principal balance outstanding of $650,000 related to this revolving note. This revolving note matures on December 15, 2012, is annually renewable and requires us to make monthly interest payments at a variable rate of 30-day LIBOR plus 1.75%, or 1.98% at September 30, 2012. Under this revolving note, we are required to have a minimum tangible net worth equal to or greater than $2.5 million at the end of each fiscal year, and we are in compliance with this covenant. As of September 30, 2012, we expect to renew the revolving note in December 2012.

We believe our premium revenues, cash, investments and working capital lines of credit are sufficient to meet our short-term and long-term liquidity needs. In the short-term, we are obligated to make payments related to our contractual obligations such as our healthcare services expense, building mortgage, and our capital and operating leases and other commitments, including future payment of key employee and director deferred compensation obligations. In the long-term, we will continue to be obligated to make payments related to our other contractual obligations. We will also be obligated in certain circumstances to repurchase the Redeemable Common Shares of our provider shareholders who die, become permanently disabled or retire. We will also be obligated in certain circumstances to repurchase the Redeemable Institutional Preferred Shares upon redemption request. Our Board of Directors establishes limitations on the amount of share redemptions each year. While we are not able to estimate future redemptions of our Redeemable Common Shares and Redeemable Institutional Preferred Shares, we believe our cash balances, investment securities, operating cash flows, and borrowing capacity, taken together, provide adequate resources to fund ongoing operating and regulatory requirements and fund future expansion opportunities and capital expenditures in the next twelve months.

Our largest subsidiary, Dental Care Plus Inc, (“DCP”), operates in states that regulate its payment of dividends and debt service on inter-company loans, as well as other inter-company cash transfers and require minimum levels of equity as well as limit investments to approved securities. The amount of dividends that may be paid by DCP, without prior approval by state regulatory authorities, is limited based on statutory income and statutory capital and surplus. Even if prior approval is not required, prior notification must be provided to state agencies in Ohio, Kentucky and Indiana before paying a dividend. There were no dividends declared or paid by DCP in the 2012 or 2011 periods.

A.M. Best Company assigns a rating to companies that have, in their opinion, an ability to meet their ongoing obligations to policyholders, but are financially vulnerable to adverse changes in underwriting and economic conditions. In June 2012, A.M. Best Company upgraded our financial strength rating to B (Fair) from B- (Fair) with a positive outlook based on DCP’s positive operating performance and improved capitalization. Our A.M. Best rating is a measure of our financial strength relative to other insurance companies and is not a recommendation to buy, sell or hold securities. The rating assigned by A.M. Best Company is based, in part, on the ratio of our fully-insured premium revenue to our statutory capital and surplus.

We attempt to reduce overall risk by maintaining a well-diversified fixed-maturity portfolio. We invest in certificates of deposits, investment grade corporate bonds and money market funds, targeting what we believe to be optimal risk-adjusted after-tax yields. Risk, in this context, includes interest rate, call, reinvestment rate, credit and liquidity risk. We do not make a concerted effort to alter duration on a portfolio basis in response to anticipated movements in interest

rates. By continually investing in certificates of deposits, money market funds and investment grade corporate bonds, we believe the portfolio mitigates the impact of adverse economic factors. As of September 30, 2012, we had approximately $2,110,000 or 74% of the total fair value of investment grade corporate bonds with a Standard & Poor’s rating of A- or better. The remaining investment grade corporate bonds had a fair value of approximately $726,000 with a Standard & Poor’s rating between BB+ and BBB+. The weighted average yield-to-book value of our investment grade corporate bonds was approximately 4.24% at September 30, 2012. The weighted average maturity of our investment grade corporate bonds was 8.19 years at September 30, 2012.

Our regulated subsidiary’s state of domicile has statutory risk-based capital, or RBC, requirements for health and other insurance companies largely based on the NAIC’s RBC Model Act. These RBC requirements are intended to measure capital adequacy, taking into account the risk characteristics of an insurer’s investments and products. The NAIC sets forth the formula for calculating the RBC requirements, which are designed to take into account asset risks, insurance risks, interest rate risks and other relevant risks with respect to an individual insurance company’s business. In general, an insurance company must submit a report of its RBC level to the state insurance department or insurance commissioner, as appropriate, at the end of each calendar year. Our subsidiary’s risk-based capital as of December 31, 2011, which was the most recent date for which reporting was required, was in excess of all mandatory RBC thresholds.

Deferred acquisition costs are those incremental direct costs related to the successful acquisition of new and renewal business. These incremental direct costs and other costs are those that are essential to the contract transaction and would not have been incurred had the contract transaction not occurred. Such incremental direct costs include commissions, costs of contract issuance and underwriting, premium taxes and other costs the Company incurs to acquire successful new business or renew existing business. The Company defers policy acquisition costs and amortizes them over the estimated life of the contracts, which are short-duration in nature, in proportion to premiums earned.

Effective January 1, 2012, the Financial Accounting Standards Board (“FASB”) amended the guidance for deferred acquisition costs and requires that only incremental direct costs of successful contract acquisition be capitalized. These incremental direct costs and other costs are those that are essential to the contract transaction and would not have been incurred had the contract transaction not occurred. On January 1, 2012, the impact of adoption on redeemable shares totaled approximately $125,000, net of tax. The Company has applied the retrospective method for financial statement presentation and note disclosures for the prior periods reported.

We estimate liabilities for both incurred but not reported (“IBNR”) and reported claims in process by employing actuarial methods that are commonly used by health insurance actuaries and meet actuarial standards of practice. These actuarial standards of practice require that claim liability estimates be adequate under moderately adverse circumstances. The Company’s consulting actuary assists us in making these estimates. Since our liability for claims payable is based on actuarial estimates, the amount of claims eventually paid for services provided prior to the balance sheet date could differ from the estimated liability. Any such differences are recognized in the condensed consolidated statements of comprehensive income for the period in which the differences are identified. Historically, such differences have not been material.

We develop our estimate for claims payable liability using actuarial methodologies and assumptions, primarily based on historical claim payments and claim receipt patterns, as well as historical dental cost trends. Depending on the period for which incurred claims are estimated, we apply a different method in determining our estimate. For periods prior to the most recent month, we calculate a “completion factor” which indicates the percentage of claims payable estimated for a prior period that have been paid as of the end of the current reporting period. We use the completion factor to determine historical patterns over a rolling 12-month period, made consistent by making adjustments for known changes in claims in process levels and known changes in claim payment processes. For the most recent month, we calculate a “claims trend factor” that estimates incurred claims primarily from a trend analysis based upon PMPM claims trends developed from our historical experience in the preceding months, adjusted for known provider contracting changes, changes in benefit levels, seasonality and consideration of any subsequent actual claims data available. When developing our estimate for claims payable liability as of December 31, 2011, we considered actual paid claim data from January 2012. As a result, we were able to use the completion factors approach for all historical months at December 31, 2011.

We have not changed the key actuarial methodologies used by management to estimate the IBNR and reported claims in process components of our claims payable liability during the periods presented, and management has not adjusted any of the key methodologies used in calculating the most recent estimate of the IBNR and reported claims in process components of our claims payable liability. Our assumptions in the 2012 quarter for the claims trend factor used to estimate incurred claims for September 30, 2012 are consistent with the dental services utilization levels we experienced in the prior year and our expectation that this level of utilization will continue in the future.

The table set forth below illustrates how our operating results are affected when there is a variance between estimated claims expense and actual claims expense. The table shows the sensitivity of the estimated fully-insured incurred claims payable liability to fluctuations in the expected completion factors and claims trend factors that were used to estimate the claims payable liability as of September 30, 2012 within variance ranges historically experienced.

Based on historical experience, we believe the completion factors we use to estimate outstanding IBNR and reported claims in process are reliable for predicting actual claims paid at future times, with a variance range of approximately one-half of one percent, plus or minus. The claims trend factors we use to estimate outstanding IBNR and reported claims in process for the most recent month are somewhat less reliable based on historical experience, with a variance range of approximately five percent, plus or minus. We have found that the estimated claims trend factor can be higher or lower than what the paid claims data indicates with the passage of time primarily because of factors beyond our control, such as the level of utilization of services by dental members and the expected and actual mix of the types of services received by dental members.

In 2012, our first quarter healthcare services expense was lower than the first quarter of 2011. This decrease was primarily due to a lower level of fully-insured dental HMO/IND and fully-insured dental PPO healthcare services expense on a PMPM basis. This decrease is primarily the result of the 10% withhold on the in-network portion of the fully-insured dental PPO that was in effect in the first quarter of 2012 but not in the first quarter of 2011. In the second quarter of 2012, our healthcare services expense on a PMPM basis was higher than the second quarter of 2011. Given the 10% withhold on the in-network portion of the fully-insured dental PPO was in effect during the second quarter of both 2012 and 2011, the increase in healthcare services expense on a PMPM basis was the result of higher dental services utilization in the 2012 quarter. In the third quarter of 2012, our healthcare services expense on a PMPM basis was lower than that in the third quarter of 2011 as a result of lower dental services utilization in the third quarter of 2012.

Based on our healthcare services expense on a PMPM basis that adjusts the quarterly healthcare services expense for membership volume changes, our dental plan members have historically used their dental plan benefits according to a seasonal pattern. In general, claims on a PMPM basis are generally lower in the second and fourth quarter than in the first quarter and the third quarter. The higher third quarter claim level on a PMPM basis is primarily due to the high level of dental services used in July and August by student members prior to returning to school. Use of dental services is lowest in the fourth quarter due to the holiday season and the fact that a portion of our members have already reached their maximum annual benefit level for the year. The following shows these trends in tabular form:

Market risk is the risk that we will incur investment losses or increased interest expense due to adverse changes in market rates and prices. Our market risk exposures are substantially related to our investment portfolio and the impact of interest rate changes on these securities. In addition, interest rate changes can affect future interest expense for debt obligations that have a variable rate of interest associated with them.

At September 30, 2012 and December 31, 2011, respectively, our investment portfolio consisted of approximately $87,000 and $108,000 of institutional money market funds. Our portfolio also included approximately $2,836,000 and $2,791,000 of investment grade corporate bonds and approximately $1,215,000 and $1,206,000 of investments in FDIC-insured bank certificates of deposits at September 30, 2012 and December 31, 2011, respectively. In August 2011, we engaged a fixed income investment manager to manage our investment grade corporate bond portfolio under the Company’s direction. We have instructed our investment manager to continue to limit our corporate bond investments to investment grade corporate bonds, and invest in investment grade corporate bonds with maturities of up to ten years. As a result, as of August 2011, we reclassified our investment grade corporate bond portfolio from held to maturity to available for sale. We expect investment in investment grade corporate bonds with longer durations will result in increased investment income in the balance of 2012 and beyond. In July 2012, we instructed our investment manager to sell approximately $500,000 of investment grade corporate bonds with maturities of up to ten years and invest the proceeds in investment grade corporate bonds with maturities up to five years. At September 30, 2012, our portfolio included approximately $292,000 of these shorter duration investment grade corporate bonds.

There is increased interest rate risk associated with our investment in longer duration investment grade corporate bonds. We have evaluated the impact on the invested portfolio’s fair value considering an immediate 100 basis point change in interest rates. A 100 basis point increase in interest rates would result in an approximate $193,000 decrease in fair value, whereas a 100 basis point decrease in interest rates would result in an approximate $191,000 increase in fair value. The investment grade corporate bonds with a fair value of $2,836,000 and $2,791,000 at September 30, 2012 and December 31, 2011, respectively, are all classified as available-for-sale. The certificates of deposit with a fair value of $1,214,000 at September 30, 2012 and $1,206,000 at December 31, 2011 are all classified as available-for-sale.

At September 30, 2012 and December 31, 2011, we had a mortgage note with a bank with an outstanding principal balance of $690,000 and $780,000, respectively, with a variable rate based on LIBOR plus 1.75%. However, in June 2003, we entered into a variable to fixed interest rate swap contract that effectively eliminated the interest rate risk exposure on all but $300,000 of the outstanding loan principal. Management estimates that a 100 basis point increase in interest rates would decrease our annual pre-tax earnings by $3,000.

At September 30, 2012 and December 31, 2011, we had a revolving note with a commercial bank with an outstanding principal balance of $650,000 with a variable rate based on LIBOR plus 1.75%. Management estimates that a 100 basis point increase in interest rates would decrease our annual pre-tax earnings by $6,500.

An evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), of the design and effectiveness of the Company’s disclosure controls and procedures (as defined in Securities Exchange Act Rules 13a-15(e) and 15d-15(e)) as of September 30, 2012. Based on the evaluation, the Principal Executive Officer and Principal Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2012.

There were no changes in the Company’s internal control over financial reporting (as defined in Securities Exchange Act Rules 13a-15(f) and 15(d)-15(f)) during the three and nine months ended September 30, 2012 that materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

We are not a party to any pending legal proceedings that we believe would, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations or cash flows.

Certain factors may have a material adverse effect on our business, financial condition and results of operations and you should carefully consider them. It is not possible to predict or identify all such factors. For discussion of our potential risks or uncertainties, refer to Part I, Item 1A, Risk Factors, included in our 2011 Annual Report on Form 10-K. There have been no material changes to the risk factors disclosed in our 2011 Annual Report on Form 10-K.

In August 2012, the Company sold and issued 20 Class B Redeemable Common Shares in a private placement to a member of the Company’s Board of Directors, at a price of $711.48 per share.

We repurchased and retired 3 Class A Redeemable Common Shares and 57 Class B Redeemable Common Shares during the three months ended September 30, 2012 as follows:


Exhibits

31.1		CEO certifications pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

31.2		CFO certifications pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

32		CEO and CFO certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101		Financial information and Notes to Financial Statements for the quarter ended September 30, 2012, formatted in XBRL (Extensible Business Reporting Language).

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Ohio		20-1291244
(State or Other Jurisdiction of Incorporation or Organization)		(IRS Employer Identification No.)

100 Crowne Point Place Sharonville, Ohio		45241
(Address of Principal Executive Office)		(Zip Code)


	PART I – FINANCIAL INFORMATION
		PAGE
Item 1.	Financial Statements (unaudited)		1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		15
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		26
Item 4.	Controls and Procedures		27

	PART II – OTHER INFORMATION

Item 1.	Legal Proceedings		28
Item 1A.	Risk Factors		28
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		28
Item 3.	Defaults Upon Senior Securities		28
Item 4.	Mine Safety Disclosures		28
Item 5.	Other Information		28
Item 6.	Exhibits		29
	Signatures		30


	September 30,		December 31,
	2012		2011
ASSETS
INVESTMENTS:
Fixed maturities, available for sale at fair value, amortized cost of $3,503,000 and $3,727,000 at September 30, 2012 and December 31, 2011, respectively	$	3,749,605	$	3,797,511
Short-term investments, available for sale at fair value, amortized cost of $387,000 and $308,000 at September 30, 2012 and December 31, 2011, respectively		388,800		307,853

Total investments		4,138,405		4,105,364
CASH AND CASH EQUIVALENTS		8,659,202		6,976,358
ACCRUED INVESTMENT INCOME		21,006		39,664
ACCOUNTS RECEIVABLE, net of allowance of $15,273 and $15,293 at September 30, 2012 and December 31, 2011, respectively		654,206		567,200
UNBILLED ACCOUNTS RECEIVABLE		26,522,727		21,219,366
DEFERRED ACQUISITION COSTS		1,694,304		1,408,214
PROPERTY AND EQUIPMENT, net of depreciation and amortization of $2,561,225 and $2,365,446 at September 30, 2012 and December 31, 2011, respectively		2,161,936		2,300,308
OTHER ASSETS		1,636,478		1,660,055

TOTAL ASSETS	$	45,488,264	$	38,276,529

LIABILITIES, REDEEMABLE SHARES AND SHAREHOLDERS’ EQUITY
CLAIMS PAYABLE	$	2,842,710	$	2,801,468
UNEARNED PREMIUM REVENUE		28,090,160		22,456,802
OTHER PAYABLES AND ACCRUALS		3,913,391		4,042,879
REVOLVING NOTE		650,000		650,000
MORTGAGE LOAN PAYABLE		690,000		780,000
CAPITAL LEASE OBLIGATION		138,442		218,939
DEFERRED COMPENSATION		1,410,996		1,196,383

TOTAL LIABILITIES		37,735,699		32,146,471

COMMITMENTS AND CONTINGENCIES

REDEEMABLE PREFERRED AND COMMON SHARES:
Provider Preferred-2009 Series Redeemable Preferred Shares, no par value, cumulative 5% dividend—authorized, 5,000 shares; issued none
Institutional Preferred Shares-2010 Series, no par value, cumulative 5% dividend—authorized, 300 shares; issued and outstanding, 300 shares at September 30, 2012 and December 31, 2011, respectively		361,701		342,464
Institutional Preferred Shares-2012 Series, no par value, cumulative 5% dividend—authorized, 1,000 shares; issued and outstanding, 1,000 shares at September 30, 2012 and zero at December 31, 2011, respectively		1,044,027
Class A, Redeemable Common Shares, no par value—authorized, 7,500 shares; issued and outstanding, 575 and 596 shares at September 30, 2012 and December 31, 2011, respectively		439,214		409,211
Class B Redeemable Common Shares, no par value—authorized, 100,000 shares; issued and outstanding, 7,734 and 7,827 shares at September 30, 2012 and December 31, 2011, respectively		5,907,623		5,378,383

Total redeemable preferred and common shares		7,752,565		6,130,058

SHAREHOLDERS’ EQUITY—Preferred Shares; no par value—authorized, 93,700 shares; issued, none

TOTAL LIABILITIES, REDEEMABLE SHARES AND SHAREHOLDERS’ EQUITY	$	45,488,264	$	38,276,529


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2012			2011			2012			2011
REVENUES
Premium revenue	$	20,355,918		$	19,647,588		$	59,777,226		$	57,272,071
Investment income		34,232			22,071			97,916			75,911
Realized gains on investments, net		39,502			14,859			39,545			14,859
Other income		18,309			15,405			50,813			45,680

Total revenues		20,447,961			19,699,923			59,965,500			57,408,521

EXPENSES
Healthcare services expense		16,091,750			15,999,201			48,252,095			47,373,347

Insurance expense:
Salaries and benefits expense		1,302,389			1,193,463			3,973,354			3,746,599
Commission expenses and other acquisition costs		952,644			925,697			2,847,863			2,737,311
Other insurance expense		1,113,629			1,133,917			3,613,075			3,289,601

Total insurance expense		3,368,662			3,253,077			10,434,292			9,773,511

Total expenses		19,460,412			19,252,278			58,686,387			57,146,858

INCOME BEFORE INCOME TAX		987,549			447,645			1,279,113			261,663

INCOME TAX EXPENSE		366,182			162,741			467,672			95,639

NET INCOME ON REDEEMABLE SHARES		621,367			284,904			811,441			166,024

OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX
Change in the fair value of interest rate swap		1,840			1,754			5,572			4,887
Change in the fair value of investments		61,308			(26,177	)		137,569			(31,563	)
Reclassification adjustment for gains included in net income		(26,071	)		(9,807	)		(26,071	)		(9,807	)
Conversion of investments from Held-to-Maturity to Available-for-Sale					41,987						41,987

Total other comprehensive income		37,077			7,757			117,070			5,504

TOTAL COMPREHENSIVE INCOME	$	658,444		$	292,661		$	928,511		$	171,528

Large accelerated filer

Accelerated filer

Non-accelerated filer

x (Do not check if smaller reporting company)

Smaller reporting Company


	Redeemable Common Shares												Redeemable Preferred Shares														Shareholders’ Equity
	Class A						Class B						Institutional Preferred 2010-Series					Institutional Preferred 2012-Series				Provider Preferred 2009-Series					Retained Earnings			Other Accumulated Comprehensive Income (Loss)			Total
	Number of Shares			Amount			Number of Shares			Amount			Number of Shares		Amount			Number of Shares		Amount		Number of Shares		Amount			Retained Earnings			Other Accumulated Comprehensive Income (Loss)			Total
Balance at December 31, 2011		596		$	409,211			7,827		$	5,378,383			300	$	342,464
Net income																											$	811,441					$	811,441
Change in fair value of interest rate swap (net of income tax expense of $2,870)																														$	5,572			5,572
Change in fair value of investments (net of income tax expense of $70,869)																															137,569			137,569
Reclassification adjustment for gains included in net income (net of tax benefit of $13,430)																															(26,071	)		(26,071	)
Dividends declared																												(227,298	)					(227,298	)
Redeemable Shares issued								32			22,575								1,000	$	1,000,000
Class A Common Shares exchanged for Class B Common Shares		(14	)		(9,819	)		14			9,819
Redeemable Shares repurchased		(7	)		(4,898	)		(139	)		(96,383	)
Accretion of shares to redemption value					44,720						593,229					19,237					44,027							(584,143	)		(117,070	)		(701,213	)

Balance at September 30, 2012		575		$	439,214			7,734		$	5,907,623			300	$	361,701			1,000	$	1,044,027			$			$			$			$


	Redeemable Common Shares												Redeemable Preferred Shares														Shareholders’ Equity
	Class A						Class B						Institutional Preferred 2010-Series					Institutional Preferred 2012-Series				Provider Preferred 2009-Series					Retained Earnings			Other Accumulated Comprehensive Income (Loss)			Total
	Number of Shares			Amount			Number of Shares			Amount			Number of Shares		Amount			Number of Shares		Amount		Number of Shares		Amount			Retained Earnings			Other Accumulated Comprehensive Income (Loss)			Total
Balance as reported December 31 , 2010		608		$	384,825			7,476		$	4,731,827		$	300	$	326,458							330	$	185,447
Cumulative effect of a change in accounting for deferred policy acquisition costs, net of tax																											$	(164,533	)				$	(164,533	)
Dilution of shares to redemption value					(11,731	)					(144,017	)				(3,064	)								(5,721	)		164,533						164,533

Balance as adjusted December 31, 2010		608			373,094			7,476			4,587,810			300		323,394							330		179,726
Net Income																												166,024						166,024
Change in fair value of interest rate swap (net of income tax expense of $2.519)																														$	4,887			4,887
Change in fair value of investments (net of income tax benefit of $16,368)																															(31,563	)		(31,563	)
Reclassification adjustment for gains included in net income (net of tax benefit of $5,052)																															(9,807	)		(9,807	)
Conversion of investments from Held-to-Maturity to Available-for-Sale (net of income tax expense of $21,630)																															41,987			41,987
Dividends declared																												(12,242	)					(12,242	)
Class A Common Shares exchanged for Class B Commons Shares		(2	)		(1,232	)		2			1,232
Redeemable Shares repurchased		(9	)		(5,474	)		(133	)		(81,734	)
Accretion of shares to redemption value					11,111						137,443					5,203									5,529			(153,782	)		(5,504	)		(159,286	)

Balance at September 30, 2011		597		$	377,499			7,345		$	4,644,751			300	$	328,597				$			330	$	185,255		$			$			$


	September 30, 2012		December 31, 2011
			As Reported		As Restated		Difference
Deferred acquisition costs	$	1,694,304	$	1,598,323	$	1,408,214	$	(190,109	)
Other assets		1,636,478		1,595,418		1,660,055		64,637
Total assets		45,488,264		38,402,001		38,276,529		(125,472	)
Redeemable shares		7,752,565		6,255,530		6,130,058		(125,472	)


	Three months ended
	September 30, 2012		September 30, 2011
			As Reported		As Restated		Difference
Commission expenses and other acquisition costs	$	952,644	$	941,296	$	925,697	$	15,599
Net Income on Redeemable Shares		621,367		274,609		284,904		10,295

	Nine months ended
	September 30, 2012		September 30, 2011
			As Reported		As Restated		Difference
Commission expenses and other acquisition costs	$	2,847,863	$	2,725,455	$	2,737,311	$	(11,856	)
Net Income on Redeemable Shares		811,411		173,849		166,024		(7,825	)


	Available-for-Sale
September 30, 2012	Amortized Cost		Fair Value		% of Total Value
Maturity dates occurring:
Less than 1 year (Two certificates of deposit)	$	300,000	$	301,423		7.4	%
Greater than 1 year (Six certificates of deposit and thirty-three corporate bonds)		3,503,130		3,749,605		92.6	%

Total	$	3,803,130	$	4,051,028		100.0	%


	Available-for-Sale
December 31, 2011	Amortized Cost		Fair Value		% of Total Value
Maturity dates occurring:
Less than 1 year (One certificate of deposit)	$	200,000	$	200,154		5.0	%
Greater than 1 year (Seven certificates of deposit and twenty-three corporate bonds)		3,727,359		3,797,511		95.0	%

Total	$	3,927,359	$	3,997,665		100.0	%


	Individual Director’s Share Awards			Weighted Average Grant Date Fair Value		Key Employee Share Awards		Weighted Average Grant Date Fair Value
Non-vested awards at January 1, 2012							148.4	$	788
Granted		165.0		$	723		220.0		753

Forfeited		(13.0	)		723

Non-vested awards at September 30, 2012		152.0		$	723		368.4	$	767


	Three Months Ended September 30, 2012						Three Months Ended September 30, 2011
	Revenues- External Customers		Healthcare Services Expense		Total		Revenues- External Customers		Healthcare Services Expense		Total
Reportable segments:
Fully-insured dental HMO/Indemnity	$	10,952	$	8,204	$	2,748	$	10,719	$	8,306	$	2,413
Fully-insured dental PPO		2,862		2,350		512		2,370		2,127		243
Self-insured dental		6,426		5,537		889		6,438		5,566		872
Corporate, all other		116				116		121				121

Total	$	20,356	$	16,091		4,265	$	19,648	$	15,999		3,649

Investment income						34						22
Realized gains on investments, net						40						15

Other income						18						15
Insurance expense						3,369						3,253

Income before income tax					$	988					$	448

Total assets-corporate					$	45,488					$	45,519


	Nine Months Ended September 30, 2012						Nine Months Ended September 30, 2011
	Revenues- External Customers		Healthcare Services Expense		Total		Revenues- External Customers		Healthcare Services Expense		Total
Reportable segments:
Fully-insured dental HMO/Indemnity	$	32,793	$	25,485	$	7,308	$	31,765	$	25,357	$	6,408
Fully-insured dental PPO		8,420		7,113		1,307		7,127		6,503		624
Self-insured dental		18,197		15,654		2,543		18,015		15,513		2,502
Corporate, all other		367				367		365				365

Total	$	59,777	$	48,252		11,525	$	57,272	$	47,373		9,899

Investment income						98						76
Realized gains on investments, net						40						15

Other income						51						46
Insurance expense						10,435						9,774

Income before income tax					$	1,279					$	262

Total assets-corporate					$	45,488					$	45,519


	September 30, 2012						December 31, 2011
	Level 1		Level 2		Total Balance		Level 1		Level 2		Total Balance
Assets
Fixed maturities
Federally-insured certificates of deposit			$	913	$	913			$	1,006	$	1,006
Investment grade corporate bonds				2,836		2,836				2,791		2,791
Short-term investments
Money market funds	$	87				87	$	108				108
Federally-insured certificates of deposit				301		301				200		200
Deferred compensation investments (a)
Equity mutual fund investments		346				346		258				258
State guarantee fund deposits (b)
Government securities		226				226		235				235
Federally-insured certificates of deposit				50		50				50		50

Total	$	659	$	4,100	$	4,759	$	601	$	4,047	$	4,648

Liabilities
Interest rate swap (c)			$	8	$	8			$	16	$	16

Total	$		$	8	$	8	$		$	16	$	16


	As of		As of
	September 30, 2012		September 30, 2011		Change
Membership:
Fully-insured dental HMO/IND		148,300		146,800		1.0	%
Fully-insured dental PPO		41,400		38,300		8.1	%
Self-insured dental		84,400		82,800		1.9	%
Corporate, all other		22,400		22,700		(1.3	%)

Total membership		296,500		290,600		2.0	%


	Three months ended		Three months ended
	September 30, 2012		September 30, 2011		Change
Premium revenue:
Fully-insured dental HMO/IND	$	10,952	$	10,719		2.2	%
Fully-insured dental PPO		2,862		2,370		20.8	%
Self-insured dental		6,426		6,438		(0.2	%)
Corporate, all other		116		121		(4.1	%)

Total premium revenue		20,356		19,648		3.6	%

Investment income		34		22		54.5	%

Realized gains on investments, net		40		15		166.7	%

Other income		18		15		20.0	%

Total revenue		20,448		19,700		3.8	%

Healthcare services expense:
Fully-insured dental HMO/IND		8,204		8,306		(1.2	%)
Fully-insured dental PPO		2,350		2,127		10.5	%
Self-insured dental		5,537		5,566		(0.5	%)
Corporate, all other

Total healthcare service expense		16,091		15,999		0.6	%

Insurance expense		3,369		3,253		3.6	%

Income tax expense		367		163		125.2	%

Net Income on redeemable shares	$	621	$	285		117.9	%


	Nine months ended		Nine months ended
	September 30, 2012		September 30, 2011		Change
Premium revenue:
Fully-insured dental HMO/IND	$	32,793	$	31,765		3.2	%
Fully-insured dental PPO		8,420		7,127		18.1	%
Self-insured dental		18,197		18,015		1.0	%
Corporate, all other		367		365		0.5	%

Total premium revenue		59,777		57,272		4.4	%

Investment income		98		76		28.9	%

Realized gains on investments, net		40		15		166.7	%

Other income		51		46		10.9	%

Total revenue		59,966		57,409		4.5	%

Healthcare services expense:
Fully-insured dental HMO/IND		25,485		25,357		0.5	%
Fully-insured dental PPO		7,113		6,503		9.4	%
Self-insured dental		15,654		15,513		0.9	%
Corporate, all other

Total healthcare service expense		48,252		47,373		1.9	%

Insurance expense		10,435		9,774		6.8	%

Income tax expense		468		96		387.5	%

Net Income on redeemable shares	$	811	$	166		388.6	%


	Nine months ended September 30, 2012		Nine months ended September 30, 2011
Net cash provided by operating activities	$	1,094	$	459
Net cash provided by (used in) investing activities		82		(270	)
Net cash provided by (used in) financing activities		507		(313	)

Increase (decrease) in cash and cash equivalents	$	1,683	$	(124	)


Completion Factor (a)				Claims Trend Factor (b)
		Estimated claims				Estimated claims
(Decrease)		payable liability		(Decrease)		payable liability
Increase		as of		Increase		as of
In Factor		9/30/2012		In Factor		9/30/2012
(0.5)%			3,072,970	(5)%			2,686,361
0%	(estimate used)		2,842,710	0%	(estimate used)		2,842,710
0.5%			2,711,945	5%			3,007,587


	Healthcare Service Expense
	2012				2011
	$000’s		$PMPM		$000’s		$PMPM
First Quarter	$	16,240	$	19.83	$	16,190	$	20.31
Second Quarter		15,920		19.43		15,184		19.11
Third Quarter		16,092		19.61		15,999		19.98
Fourth Quarter						14,978		18.65


Period	Total Class A shares purchased			Total Class B shares purchased			Average price paid per share		Total Number of Shares Purchased as Part of a Publicly Announced Plans or Programs		Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
July 1 – July 31, 2012		1	^(a)		11	^(a)	$	694.63		0		N/A
August 1 – August 31, 2012		1	^(a)		11	^(a)	$	711.48		0		N/A
September 1 – September 30, 2012		1	^(a)		35	^(a)	$	691.79		0		N/A


	DCP HOLDING COMPANY

November 14, 2012	By:	/s/ Anthony A. Cook
		Anthony A. Cook.
		President, Chief Executive Officer and Director
		Principal Executive Officer

November 14, 2012	By:	/s/ Robert C. Hodgkins, Jr.
		Robert C. Hodgkins, Jr.
		Vice President and Chief Financial Officer
		Principal Executive Officer


Exhibit No.		Item

31.1		Certifications pursuant to Section 302 of Sarbanes-Oxley Act of 2002

31.2		Certifications pursuant to Section 302 of Sarbanes-Oxley Act of 2002

32		Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101		Financial information and Notes to Financial Statements for the quarter ended September 30, 2012, formatted in XBRL (Extensible Business Reporting Language).